Optimind Pharma (XCNQ:OMND) Other Long-Term Liabilities : C$0.00 Mil (As of Nov. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma Other Long-Term Liabilities?

Optimind Pharma's other long-term liabilities for the quarter that ended in Nov. 2024 was C$0.00 Mil.

Optimind Pharma's annual other long-term liabilities declined from Feb. 2022 (C$-0.00 Mil) to Feb. 2023 (C$-0.00 Mil) but then increased from Feb. 2023 (C$-0.00 Mil) to Feb. 2024 (C$0.00 Mil).

Optimind Pharma Other Long-Term Liabilities Historical Data

The historical data trend for Optimind Pharma's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma Other Long-Term Liabilities Chart

Optimind Pharma Annual Data

Trend

Feb22

Feb23

Feb24

Other Long-Term Liabilities

Optimind Pharma Quarterly Data
	Jun21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
Other Long-Term Liabilities	Get a 7-Day Free Trial								-	-	-	-	-

Optimind Pharma Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Optimind Pharma Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Optimind Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

77 King Street West, Suite 3000, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8

Website

https://www.optimindpharma.com

Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. It is also partnered with developers of psilocybin-associated treatments and products to further expand its treatment and program offerings.

Optimind Pharma Headlines

No Headlines